M Silvasti

1.1k total citations
57 papers, 921 citations indexed

About

M Silvasti is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Nutrition and Dietetics. According to data from OpenAlex, M Silvasti has authored 57 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 41 papers in Physiology and 5 papers in Nutrition and Dietetics. Recurrent topics in M Silvasti's work include Asthma and respiratory diseases (41 papers), Inhalation and Respiratory Drug Delivery (33 papers) and Respiratory and Cough-Related Research (26 papers). M Silvasti is often cited by papers focused on Asthma and respiratory diseases (41 papers), Inhalation and Respiratory Drug Delivery (33 papers) and Respiratory and Cough-Related Research (26 papers). M Silvasti collaborates with scholars based in Finland, United Kingdom and Germany. M Silvasti's co-authors include Kari Laurikainen, P Karttunen, H Tukiainen, M Vidgren, Matti Uusitupa, Gary R. Pitcairn, Stephen P. Newman, Ilkka Penttilä, K. Malmström and Peter H. Hirst and has published in prestigious journals such as American Journal of Clinical Nutrition, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

M Silvasti

57 papers receiving 867 citations

Peers

Countries citing papers authored by M Silvasti

Since Specialization

Citations

This map shows the geographic impact of M Silvasti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Silvasti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Silvasti more than expected).

Fields of papers citing papers by M Silvasti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Silvasti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Silvasti. The network helps show where M Silvasti may publish in the future.

Co-authorship network of co-authors of M Silvasti

This figure shows the co-authorship network connecting the top 25 collaborators of M Silvasti. A scholar is included among the top collaborators of M Silvasti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Silvasti. M Silvasti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety of formoterol after cumulative dosing via Easyhaler® and Aerolizer® 2005 ·Respiratory Medicine ·Jukka Randell, Antti Saarinen, (unknown), Mikko Vahteristo, M Silvasti, (unknown)	11
2	Clinically Equivalent Bronchodilatation Achieved with Formoterol Delivered via Easyhaler<sup>®</sup> and Aerolizer<sup>®</sup> 2005 ·Respiration ·Rūta Dubakienė, (unknown), Raimundas Sakalauskas, Mikko Vahteristo, M Silvasti, (unknown)	5
3	Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method 2004 ·British Journal of Clinical Pharmacology ·(unknown), Merja Kirjavainen, (unknown), (unknown), Mikko Vahteristo, M Silvasti, (unknown)	31
4	Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients 2002 ·Respiratory Medicine ·H Tukiainen, Paula Rytilä, Kirsi Hämäläinen, M Silvasti, (unknown)	17
5	A comparison of the lung deposition of budesonide from Easyhaler®, Turbuhaler®and pMDI plus spacer in asthmatic patients 2001 ·Respiratory Medicine ·Peter H. Hirst, (unknown), Gary R. Pitcairn, M Silvasti, Stephen P. Newman	61
6	BECLOMETHASONE DIPROPIONATE EASYHALER® IS AS EFFECTIVE AS BUDESONIDE TURBOHALER® IN THE CONTROL OF ASTHMA AND IS PREFERRED BY PATIENTS 2000 ·International Journal of Clinical Practice ·(unknown), (unknown), Kari Laurikainen, M. Leinonen, M Silvasti	15
7	Equivalence of Two Steroid-Containing Inhalers: Easyhaler Multidose Powder Inhaler Compared with Conventional Aerosol with Large-Volume Spacer 2000 ·Respiration ·Tuomas Koskela, J. Hedman, Heikki Ekroos, (unknown), M. Leinonen, M Silvasti, H Tukiainen	19
8	Efficacy of salbutamol via Easyhaler®unaffected by low inspiratory flow 2000 ·Respiratory Medicine ·Tuomas Koskela, K. Malmström, (unknown), (unknown), (unknown), M Silvasti	23
9	Application and efficacy of the multi‐dose powder inhaler, Easyhaler^Â®, in children with asthma 1999 ·Pediatric Allergy and Immunology ·K. Malmström, Ritva Sorva, M Silvasti	26
10	A New Beclomethasone Dipropionate Multidose Powder Inhaler in the Treatment of Bronchial Asthma 1998 ·Respiration ·Markku M. Nieminen, (unknown), J. Kokkarinen, (unknown), Kari Liippo, Ari Lindqvist, (unknown), (unknown), (unknown), E.-R. Salomaa, A. Sovijärvi, (unknown), M Silvasti, M Vidgren, L. A. Laitinen	12
11	Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic Patients 1998 ·Clinical Drug Investigation ·(unknown), Kristiina Alanko, (unknown), Aija Knuuttila, (unknown), Jukka Laitinen, Kaarina Lehtonen, Kari Liippo, Ari Lindqvist, (unknown), (unknown), (unknown), (unknown), M Silvasti, (unknown), Petri Toivanen, V Vilkka	8
12	Easyhaler<sup>®</sup> a Novel Multiple Dose Powder Inhaler: Clinically Equivalent to Salbutamol Metered Dose Inhaler and Easier to Use 1994 ·Respiration ·Markku M. Nieminen, M Vidgren, Kari Laurikainen, Markku Järvinen, Kari Liippo, R Tammivaara, M Silvasti	25
13	The Effect of ATP on the Ciliary Activity of Normal and Pathological Human Respiratory Mucosa in Vitro 1991 ·Acta Oto-Laryngologica ·Veijo Saano, J. Nuutinen, Pasi Virta, (unknown), P Karttunen, M Silvasti	12
14	Effects of Intravenous ATP on Tracheal Ciliary Activity, Airway Resistance and Haemodynamics in Rats 1990 ·Pharmacology & Toxicology ·Veijo Saano, (unknown), J. Nuutinen, P Karttunen, M Silvasti	5
15	The Effects of Vadocaine, Dextromethorphan, Diphenhydramine and Hydroxyzine on the Ciliary Beat Frequency in Rats in Vitro 1990 ·Pharmacology & Toxicology ·P Karttunen, M Silvasti, Pasi Virta, Veijo Saano, Juhani Nuutinen	9
16	Once-daily theophylline in the treatment of nocturnal asthma 1990 ·European Journal of Clinical Pharmacology ·V Vilkka, Pirkko Brander, A. Hakulinen, J. Laitinen, (unknown), (unknown), M Silvasti, P Karttunen	4
17	Terfenadine with or without phenylpropanolamine in the treatment of seasonal allergic rhinitis 1989 ·Clinical & Experimental Allergy ·J. Nuutinen, Elina Holopainen, Henrik Malmberg, Juhani Rinne, Jouko Suonpää, M Silvasti	5
18	Metabolic and nutritional effects of long-term use of guar gum in the treatment of noninsulin-dependent diabetes of poor metabolic control 1989 ·American Journal of Clinical Nutrition ·Matti Uusitupa, Onni Siitonen, Kaisa Savolainen, M Silvasti, Ilkka Penttilä, Markku Parviainen	68
19	Activation of mucociliary function in chronic rhinitis: a placebo-controlled study 1988 ·European Archives of Oto-Rhino-Laryngology ·J. Nuutinen, P Karttunen, M Silvasti	7
20	Long term treatment of severe hypercholesterolaemia with guar gum 1988 ·Atherosclerosis ·Jaakko Tuomilehto, M Silvasti, Antti Aro, A. Koistinen, P Karttunen, (unknown), Christian Ehnholm, Matti Uusitupa	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact